29 min listen
48. Biosimilars
FromACR on Air
ratings:
Length:
40 minutes
Released:
Feb 28, 2023
Format:
Podcast episode
Description
This week we discuss what a biosimilar is, why they’re causing such controversy and why they’ve taken seven years, since the FDA approved Amgevita, to come to market. We review the evidence behind the safety and efficacy of these drugs, the data from switching from a bio-originator to a biosimilar, and how the approval of the drugs may lower the health care costs and improve access to these medications.
Released:
Feb 28, 2023
Format:
Podcast episode
Titles in the series (86)
4. Quality Care Measurement (Oct. 15, 2019): Episode 4 is a continuation of our series focused on value-based care and how to measure quality of care. Our guest host, Dr. Vaneet Sandhu, will chat with Dr. Lisa Suter about quality measurement and improvement , and what that means for the... by ACR on Air